life science investing Aligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024
life science investing Aligos Therapeutics Announces the Completion of Enrollment in the ALG-055009 Phase 2a HERALD Study for the Treatment of MASH
life science investing Aligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
life science investing Aligos Therapeutics to Announce 1st Quarter 2024 Financial Results on May 7, 2024
Nuvau Announces Voting Results of Its Annual and Special Meeting of Shareholders and Announces the Appointment of Steven Bowles as Chair of the Board
SAGA Metals Appoints Accomplished Mining Executive Peter Hogendoorn to Board of Advisors and Engages Xander Capital Partners
Blue Lagoon Announces Major Steps Toward Production: Fully Funded, Government Inspections Passed, and Water Treatment Plant Completed
